Termeer Fellowship Supports Leaders Who Are Making An Impact On Patients

Sep 27, 2024

Building a successful biotech company requires more than money and an innovative approach to treat disease. It also requires a leader who is passionate, values-driven and people-focused — willing to go the distance to ensure patients get the life-changing therapies they need.

 

The Termeer Foundation’s Fellows Program is uniquely focused on this third ingredient, a distinctive program dedicated to supporting the person at the helm of a growing company. Through its multi-faceted curriculum and diverse network of innovators and entrepreneurs, the Termeer Fellows Program provides professional development through specific skills, competency growth, development opportunities, mentorship, executive coaching, and network building for first-time CEOs of early-stage or non-profit biotech and life sciences organizations. These offerings are designed to empower biotech leaders and provide them with the tools, resources, and support they need to build a culture and company that will thrive.

 

The Fellows Program, which began in 2018, includes a variety of both in-person and virtual events. These sessions cover a diverse range of topics, including personal leadership, team development, DEI initiatives, communication, executive presence, professional presentation, transparency, board management, strategy, problem-solving, change management, decision-making, and human resources-focused topics such as hiring, recruiting, and retention.

 

To date, 61 fellows have participated in the program, and the feedback has been extremely positive. In a survey of the 2023 Termeer Fellows, 100% said they acquired a variety of resources to continue to refine their development as a leader and that they feel connected to a network of professionals who can guide and assist them.

 

Because leadership, particularly of an early-stage biotech company, can be a lonely, isolating experience at times, the Fellows Program also helps foster a sense of community and support among the fellows in each class. In the 2023 Termeer Fellows survey, 100% indicated they have a strong professional network of peer biotech founders after participating in the program.

 

Each year, incoming fellows are selected for the Termeer Fellows Program through a competitive, stepwise process that begins with an open, online application. This selection process reflects the values that lie at the core of the Foundation’s mission and the Fellows Program: responsibility, passion, innovation, humility, and connectivity. (Applications for the 2025 fellowship year will be available online on September 30.)

As Safia Rizvi, CEO of CILA Therapeutics and a 2023 Termeer Fellow, remarked, “The Termeer Fellowship has been a transformative experience for me, both professionally and personally. It offered me the chance to learn from my peers, mentors, foundation members, and the numerous resources provided throughout the program. Most importantly, I have found a community.”

Termeer Institute Announces 2026 Transatlantic Connections Award Honorees

Shana Wang of PathCision Medicine and Arno Bisschop of Genewity Named as This Year's Recipients

The Termeer Institute today announced the recipients of the 2026 Transatlantic Connections Award (TAC), recognizing two life sciences entrepreneurs — one in the United States and one in the Netherlands — whose work has the potential to strengthen the relationship and thought partnership between the two regions’ life sciences communities.

This year’s honorees are Shana Wang, co-founder and CEO of PathCision Medicine (United States), and Arno Bisschop, CEO of Genewity (Netherlands). Both honorees join the Class of 2026 Termeer Fellows and become members of the Termeer network. Each will receive support to travel to and engage with the life sciences community in the other’s region.

The Transatlantic Connections Award was established in 2021 with support from the Termeer Institute and Health-Holland, and is rooted in the Massachusetts–Netherlands life sciences partnership formalized through a 2019 memorandum of understanding between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy.

“Scientific discovery knows no borders, and the Transatlantic Connections Award reflects that belief,” said Catharine Smith, CEO of the Termeer Institute. “Shana and Arno each bring deep expertise and a patient-first orientation to their work. We look forward to seeing the connections they build as members of the Termeer network and the exchange of ideas that will follow.”

Shana Wang, Co-Founder and CEO, PathCision Medicine

Shana Wang, co-founder and CEO of PathCision Medicine, brings a background in analytics, strategy and operational leadership to her work in life sciences. Prior to founding PathCision, she served as head of marketing and analytics at a femtech company, where she led cross-functional teams to launch new products and implemented data-driven strategies to support market growth. Earlier in her career, she worked in strategy and analytics consulting, advising Fortune 500 companies and developing predictive models to support data-informed decisions. She holds an M.A. in computational and applied mathematics from Rice University and a B.A. in economics and English from Wellesley College.

“Being named a Transatlantic Connections Award honoree is an extraordinary opportunity to learn from and contribute to a community of leaders united by a commitment to patients,” said Shana Wang, co-founder and CEO of PathCision Medicine. “I look forward to building connections across the Atlantic and bringing those perspectives to the work we are doing.”

Arno Bisschop, CEO, Genewity

Arno Bisschop is a medical doctor and entrepreneur in health and life sciences. Trained at the Amsterdam University Medical Center, he holds a PhD in orthopedic and neurosurgery and a master’s degree in management and policy in health and life sciences. Over the past decade, Bisschop has co-founded and exited several health care companies. He currently serves as CEO of Genewity, a clinical-stage company developing gene therapies for patients around the world.

“I am honored to receive the Transatlantic Connections Award and to join the Termeer Fellows community,” said Arno Bisschop, CEO of Genewity. “Collaboration across regions is essential to advancing the science and solutions that patients need, and I look forward to building those connections.”

Wang and Bisschop join a Termeer network that includes more than 600 life science industry leaders— mentors, advisors, board members and community partners — spanning nine countries and united by a shared commitment to patient-centered innovation. Fellows across the program’s history have collectively raised $3.45 billion in funding, with 73% remaining in their roles as CEOs and 87% of their companies continuing to advance. The exchange of ideas and experiences across borders is central to how the Institute drives progress, with the ultimate goal that every patient has a cure.

About the Transatlantic Connections Award 

The Transatlantic Connections Award recognizes one U.S.-based and one Netherlands-based life sciences entrepreneur annually. Honorees become members of the Termeer Fellows class and the broader Termeer network, and receive support to engage with the life sciences community in the other’s region. The award was established in 2021 with support from the Termeer Institute and Health-Holland.

About the Termeer Institute 

The Termeer Institute supports and empowers brilliant life science innovators through values-driven leadership programming, including mentorship, network development and thought leadership to advance groundbreaking, patient-centric solutions. Learn more at termeerinstitute.org.